Catalyst
Slingshot members are tracking this event:
GW Pharma (GWPH) to Commence Early Open-Label Clinical Trial in H2 2016 Evaluating CBDV (GWP42006) in Autism Spectrum Disorders
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GWPH |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 05, 2016
Occurred Source:
http://ir.gwpharm.com/releasedetail.cfm?ReleaseID=1002545
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Trial Initiation, Open-label Clinical Trial, Cbdv, Gwp42006, Autism Spectrum Disorders
